When you are raising €1M to €10M+, a pitch deck that is "good enough" is a death sentence. Investors at this level are not evaluating your vision. They are running a clinical audit of your business logic, your market command, and your team's capacity to execute under pressure.
Most founders lose not because their business is weak — but because their pitch deck has a silent killer buried inside it. A single broken vital sign that triggers the polite pass. The Pitch Vitals Check is the mandatory diagnostic to find it — before it finds your round.
At the Seed to Series A level, investors do not tell you what killed your pitch. They schedule a follow-up that never materialises. They introduce you to someone who "might be a better fit." They say the deck is compelling but the timing is off.
They do not say: "Your narrative architecture collapsed on slide three." Or: "Your unit economics triggered a risk flag we don't discuss with founders." They simply move on — and you iterate on the wrong things, burn warm introductions, and approach the next meeting carrying the same silent killer.
The result is not a bad business. It is an undiagnosed pitch. And the diagnosis is not something advisors, design agencies, or well-meaning mentors are equipped to provide at this level.
Most founders treat their pitch deck like a design project. I treat it like a high-stakes clinical diagnosis.
When you are raising €1M to €10M+, "good enough" is a death sentence. I don't review your slides — I run your entire business case through my proprietary 42-Point Surgical Scan: a rigorous, investor-grade audit designed to identify the "silent killers" in your story before they reach the partner meeting.
Instead of guessing why you're receiving polite passes, you will receive a clinical breakdown of the 7 Vital Organs of your pitch — the precise dimensions on which institutional investors evaluate whether your business case is fundable at this level.
Complete payment via Stripe. You immediately receive a concise intake form — your deck, raise target, round stage, and investor feedback to date. This pre-operative context calibrates the diagnostic to your specific business architecture.
Your deck is subjected to a rigorous audit across the 7 Vital Organs. I apply the same scrutiny a seasoned Series A partner brings to an initial deck review — with the precision of knowing exactly where most pitches fail at this level, and why.
Within 5 business days: your Investor Readiness Score, Triage Map, and Priority Fix roadmap. Clinical, specific, actionable. No vague observations. No generic advice. A precise diagnosis of your deck's condition.
The report closes with a direct clinical assessment: whether you execute the fixes independently, or whether Full Pitch Surgery is the appropriate next intervention. If surgery is recommended, your €500 applies in full.
I am not a pitch deck designer. I am not a brand strategist. My background is in high-stakes executive decision-making at the institutional level — in Supply Chain at companies like Canon Europe and Kyocera Document Solutions, where I spent over two decades building and defending business cases that had to survive the most rigorous financial and strategic scrutiny imaginable.
I know precisely what it takes to walk into a room with powerful, skeptical decision-makers and command their conviction. I know how they evaluate logic. I know what triggers doubt before a word is spoken. And I know the specific moment — often invisible to the presenter — when a business case loses the room.
After leaving corporate leadership, I conducted a systematic study of what separates funded pitches from failed ones at the Seed to Series A level: analyzing hundreds of funded decks, dissecting the investment logic of leading VC firms, and building the diagnostic framework that became the 42-Point Surgical Scan.
I do not operate at consultancy distance. I do not offer frameworks you implement yourself. I diagnose your deck with the precision of a specialist who has spent a career reading between the lines of high-stakes business cases — and I tell you exactly what is failing and why.
At the Seed to Series A level, the founders who close rounds are not always those with the strongest businesses. They are the founders whose pitch communicates Strategic Command, Unshakable Logic, and Investor-Grade Precision from the first slide. That command does not come from better design. It comes from a diagnostic that eliminates every silent killer before you walk into the room.
Secure Your 42-Point Scan €500